Budget impact analysis of universal rotavirus vaccination in the Local Health Unit 11 Empoli, Tuscany, Italy


Budget impact


Background. Rotavirus (RV) infection is the first cause of acute viral gastroenteritis in children under five years of age all over the world; it mainly affects children between six and 24 months of age and can cause serious acute diarrhoea and dehydration. The aim of this study is to perform the budget impact analysis of universal rotavirus vaccination in the Local Health Unit (LHU) 11 Empoli, Tuscany, Italy.

Methods. An ad hoc mathematical simulation model was developed to evaluate the budget impact analysis of 5-years universal rotavirus vaccination. Particularly, incidence of rotavirus gastroenteritis (RVGE), hospitalizations, nosocomial diarrhoea, medical consultations, prescriptions and accesses to emergency department were taken into account in the analysis. The direct medical costs due to RV diarrhoea and the costs of vaccination campaign were considered as the main outcome measures in the study.

Results. The adoption of universal rotavirus vaccination campaign for five years in the LHU 11 Empoli results in relevant savings due to the health cares avoided. These savings would overlapped the costs of vaccination yet from the second year after the introduction of vaccination. The saving for the Health Service would be 1.5 million Euro after five years of campaign.

Conclusions. Universal vaccination against rotavirus results clinically and economically favourable for both the Health Service and the Society perspectives.


Giaquinto C, Damme P, Huet F, et al. Reveal Study Group, author. Costs of community-acquired pediatric rotavirus gastroenteritis in 7 European countries: the REVEAL Study. J Infect Dis 2007;195(Suppl 1). [Google Scholar]

Damme P, Giaquinto C, Huet F, et al. Reveal Study Group, author. Multicenter prospective study of the burden of rotavirus acute gastroenteritis in Europe, 2004-2005: the REVEAL study. J Infect Dis 2007;195(Suppl 1). [Google Scholar]

Giaquinto C, Damme P, Huet F, et al. Reveal Study Group, author. Clinical consequences of rotavirus acute gastroenteritis in Europe, 2004-2005: the REVEAL study. Infect Dis 2007;195(Suppl 1). [Google Scholar]

Leung AKC, Kellner JD, Dele Davies, H . Rotavirus gastroenteritis. Adv Therapy 2005;22(5):476-487. Available from: http://link.springer.com/10.1007/BF02849868 doi: 10.1007/BF02849868. [Google Scholar]

Bresee JS, Glass RI, Ivanoff B, Gentsch JR. Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries.. Vaccine 1999 May;17(18):2207-2222. Available from: https://www.lens.org/lens/search?q=citation_id:10403588 PubMed PMID: 10403588. [Google Scholar]

Clark HF, Offit PA. Vaccines for rotavirus gastroenteritis universally needed for infants.. Pediatr Ann 2004;33(8):536-543. Available from: https://www.nlm.nih.gov/medlineplus/gastroenteritis.html PubMed PMID: 15354605. doi: 10.3928/0090-4481-20040801-11. [Google Scholar]

World Health Organization , author . State of the art of new vaccines research & development: Initiative for vaccine research. Geneva, Switzerland: World Health Organization; 2003. [Google Scholar]

Clark B, McKendrick M. A review of viral gastroenteritis. Curr Opin Infect Dis 2004;17(5):461-469. Available from: https://www.nlm.nih.gov/medlineplus/gastroenteritis.html PubMed PMID: 15353966. doi: 10.1097/00001432-200410000-00011. [Google Scholar]

Parashar UD, Gibson CJ, Bresee JS, Glass RI. Rotavirus and severe childhood diarrhea.. Emerg Infect Dis 2006;12(2):304-306. Available from: http://www.cdc.gov/ncidod/EID/vol12no02/05-0006.htm PubMed PMID: 16494759. doi: 10.3201/eid1202.050006. [Google Scholar]

Widdowson M, Meltzer MI, Zhang X, Bresee JS, Parashar UD, Glass RI. Cost-effectiveness and potential impact of rotavirus vaccination in the United States.. Pediatrics 2007;119(4):684-697. Available from: https://www.nlm.nih.gov/medlineplus/immunization.html PubMed PMID: 17403839. doi: 10.1542/peds.2006-2876. [Google Scholar]

Noel JS, Parker SP, Choules K, Phillips AD, Walker-Smith J, Cubitt WD. Impact of rotavirus infection on a paediatric hospital in the east end of London. J Clin Pathol 1994;47(1):67-70. Available from: http://jcp.bmj.com/cgi/pmidlookup?view=long&pmid=8132813 PubMed PMID: 8132813. doi: 10.1136/jcp.47.1.67. [Google Scholar]

Parashar UD, Chung MA, Holman RC, Ryder RW, Hadler JL, Glass RI. Use of state hospital discharge data to assess the morbidity from rotavirus diarrhea and to monitor the impact of a rotavirus immunization program: A pilot study in Connecticut.. Pediatrics 1999;104(3 Pt 1):489-494. Available from: http://www.diseaseinfosearch.org/result/2258 PubMed PMID: 10469774. doi: 10.1542/peds.104.3.489. [Google Scholar]

Piednoir E, Bessaci K, Bureau-Chalot F, Sabouraud P, Brodard V, Andréoletti L, et al. Economic impact of healthcare-associated rotavirus infection in a paediatric hospital. Journal of Hospital Infection 2003;55(3):190-195. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0195670103003037 doi: 10.1016/j.jhin.2003.07.002. [Google Scholar]

Gleizes O, Desselberger U, Tatochenko V, Rodrigo C, Salman N, Mezner Z, et al. Nosocomial rotavirus infection in European countries: a review of the epidemiology, severity and economic burden of hospital-acquired rotavirus disease.. Pediatr Infect Dis J 2006;25(1 Suppl). Available from: https://www.nlm.nih.gov/medlineplus/rotavirusinfections.html PubMed PMID: 16397425. [Google Scholar]

Muhsen K, Shulman L, Rubinstein U, et al. Rota Study Group, author. Incidence, characteristics, and economic burden of rotavirus gastroenteritis associated with hospitalization of israeli children < 5 years of age, 2007-2008. J Infect Dis 2009;200(Suppl 1). [Google Scholar]

Mast T, Walter E, Bulotsky M, et al. sving of childhood rotavirus disease on health systems in the United States. Pediatr Infect Dis J. 2010;29:e19–e25. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20135751 PubMed PMID: 20135751.

Mast TC, Chen P, Lu K, Hsu C, Lin HC, Liao W, et al. Epidemiology and economic burden of rotavirus gastroenteritis in hospitals and paediatric clinics in Taiwan, 2005-2006.. Vaccine 2010;28(17):3008-3013. Available from: https://www.nlm.nih.gov/medlineplus/gastroenteritis.html PubMed PMID: 20171305. doi: 10.1016/j.vaccine.2010.02.007. [Google Scholar]

Ehlken B, Laubereau B, Karmaus W, et al. Romod Study Group, author. Prospective population-based study on rotavirus disease in Germany. Acta Paediatr 2002;91(7):769-775. Available from: http://doi.wiley.com/10.1111/j.1651-2227.2002.tb03325.x doi: 10.1111/j.1651-2227.2002.tb03325.x. [Google Scholar]

Mangen MJ, van Duynhoven YTHP, Vennema H, van Pelt W, Havelaar AH, de Melker HE. Is it cost-effective to introduce rotavirus vaccination in the Dutch national immunization program. Vaccine 2010;28(14):2624-2635. Available from: https://www.nlm.nih.gov/medlineplus/immunization.html PubMed PMID: 20109593. doi: 10.1016/j.vaccine.2010.01.014. [Google Scholar]

Milne RJ, Grimwood K. Budget impact and cost-effectiveness of including a pentavalent rotavirus vaccine in the New Zealand childhood immunization schedule.. Value Health 2009;12(6):888-898. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1098-3015(10)60287-2 PubMed PMID: 19490550. doi: 10.1111/j.1524-4733.2009.00534.x. [Google Scholar]

Standaert B, Parez N, Tehard B, Colin X, Detournay B. Cost-effectiveness analysis of vaccination against rotavirus with RIX4414 in France. Appl Health Econ Health Policy 2008;6(4):199-216. Available from: https://www.nlm.nih.gov/medlineplus/immunization.html PubMed PMID: 19382820. doi: 10.1007/BF03256134. [Google Scholar]

Fontana M, Zuin G, Pancheri P, et al. Costs associated with outpationts diarrhoea in infants and toddlers: a nationwide study of the Italian Society of Taediatric Gastroenterology anh Hepatology (SIGEP) Dig Liver Dis. 2004;36:523–527. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15334772 PubMed PMID: 15334772.

Standaert B, Marocco A, Assael B, et al. Analisi di costo-efficacia della vaccinazione universale in Italia con il vaccino Rix4414 contro i rotavirus. PharmacoEconomics – Italian Research Articles 2008;10(1):23-35. Available from: http://link.springer.com/10.1007/BF03320638 doi: 10.1007/BF03320638. [Google Scholar]

Marocco A, Baarouk A, Gabutti G, et al. Ricoveri per enterite da Rotavirus in Italia valutati mediante analisi delle Schede di Dimissione Ospedaliera negli anni 2001-2003. Ig Sanità Pubbl 2006;62:215. [Google Scholar]

Marsella M, Raimondi L, Bergamini M, Sprocati M, Bigi E, De Sanctis V, et al. Epidemiology of rotavirus-associated hospital admissions in the province of Ferrara, Italy. Eur J Pediatr 2009 Mar;168(12):1423-1427. Available from: https://www.nlm.nih.gov/medlineplus/gastroenteritis.html PubMed PMID: 19255784. doi: 10.1007/s00431-009-0942-z. [Google Scholar]

Fm R, Delogu R, Petouchoff T, et al. The Rotanet-Italy Study Group, author. Molecular characterization of rotavirus strains from children with diarrhea in Italy, 2007-2009. J Med Virol 2011;83(9):1657-1668. Available from: http://doi.wiley.com/10.1002/jmv.22163 doi: 10.1002/jmv.22163. [Google Scholar]

Vitale F, Barbieri M, Dirodi B, et al. Una valutazione economica completa della vaccinazione estensiva contro i rotavirus con il vaccino RIX4414 a livello nazionale e regionale in Italia. Ann Ig 2013;25:43. [Google Scholar]

Vesikari T, Karvonen A, Prymula R, Schuster V, Tejedor JC, Cohen R, et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. The Lancet 2007;370(9601):1757-1763. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0140673607617449 doi: 10.1016/S0140-6736(07)61744-9. [Google Scholar]

Available from: https://http://web.rete.toscana.it/attinew/

Fantelli V, Vooren K, Garattini L. Valutazione Economica. Budget Impact Analysis: stato dell'arte in letteratura e proposta per una definizione in Italia. Quaderni di Farmacoeconomia 2011;15:7. [Google Scholar]

Jit M, Edmunds W. Evaluating rotavirus vaccination in England and Wales. Part II. The potential cost-effectiveness of vaccination.. Vaccine 2007 Mar;25(20):3971-3979. Available from: https://www.nlm.nih.gov/medlineplus/immunization.html PubMed PMID: 17400341. doi: 10.1016/j.vaccine.2007.02.070. [Google Scholar]

Tucker AW, Haddix AC, Bresee JS, Holman RC, Parashar UD, Glass RI. Cost-effectiveness analysis of a rotavirus immunization program for the United States.. JAMA 1998 May;279(17):1371-1376. Available from: https://www.nlm.nih.gov/medlineplus/immunization.html PubMed PMID: 9582045. doi: 10.1001/jama.279.17.1371. [Google Scholar]

Panatto D, Amicizia D, Giacchino R, Tacchella A, Natalizia AR, Melioli G, et al. Burden of rotavirus infections in Liguria, Northern Italy: hospitalisations and potential savings by vaccination.. Eur J Clin Microbiol Infect Dis 2011 Feb;30(8):957-964. Available from: http://www.scholaruniverse.com/ncbi-linkout?id=21293899 PubMed PMID: 21293899. doi: 10.1007/s10096-011-1180-7. [Google Scholar]

Panatto D, Amicizia D, Ansaldi F, Marocco A, Marchetti F, Bamfi F, et al. Burden of rotavirus disease and cost-effectiveness of universal vaccination in the Province of Genoa (Northern Italy).. Vaccine 2009 Feb;27(25-26):3450-3453. Available from: http://www.scholaruniverse.com/ncbi-linkout?id=19200850 PubMed PMID: 19200850. doi: 10.1016/j.vaccine.2009.01.054. [Google Scholar]

Parashar UD, Glass RI. Rotavirus Vaccines — Early Success, Remaining Questions. N Engl J Med 2009 Mar;360(11):1063-1065. Available from: http://www.nejm.org/doi/abs/10.1056/NEJMp0810154 doi: 10.1056/NEJMp0810154. [Google Scholar]

Glass RI. Unexpected benefits of rotavirus vaccination in the United States. J Infect Dis 2011;204(7):975-977. Available from: http://jid.oxfordjournals.org/lookup/doi/10.1093/infdis/jir477 doi: 10.1093/infdis/jir477. [Google Scholar]

Gagneur A, Nowak E, Lemaitre T, Segura J, Delaperrière N, Abalea L, et al. Impact of rotavirus vaccination on hospitalizations for rotavirus diarrhea: The IVANHOE study. Vaccine 2011;29(21):3753-3759. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0264410X11004038 doi: 10.1016/j.vaccine.2011.03.035. [Google Scholar]

Azzari C, Massai C, Poggiolesi C, Indolfi G, Spagnolo G, Luca, M. De , et al. Cost of varicella-related hospitalisations in an Italian paediatric hospital: comparison with possible vaccination expenses. Current Medical Research and Opinion 2007;23(12):2945-2954. Available from: http://www.tandfonline.com/doi/full/10.1185/030079907X242610 doi: 10.1185/030079907X242610. [Google Scholar]

Available from: https://www.ministerosalute.it/programmazione/sdo/

Available from: https://www.drg.it.